Holt JT - Search Results

1

Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice.

Arteaga CL, Holt JT. Arteaga CL, et al. Among authors: holt jt. Cancer Res. 1996 Mar 1;56(5):1098-1103. Cancer Res. 1996. PMID: 8640767

2

Growth retardation and tumour inhibition by BRCA1.

Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA. Holt JT, et al. Nat Genet. 1996 Mar;12(3):298-302. doi: 10.1038/ng0396-298. Nat Genet. 1996. PMID: 8589721

3

Antisense c-myc retroviral vector suppresses established human prostate cancer.

Steiner MS, Anthony CT, Lu Y, Holt JT. Steiner MS, et al. Among authors: holt jt. Hum Gene Ther. 1998 Mar 20;9(5):747-55. doi: 10.1089/hum.1998.9.5-747. Hum Gene Ther. 1998. PMID: 9551622

4

A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer.

Tait DL, Obermiller PS, Redlin-Frazier S, Jensen RA, Welcsh P, Dann J, King MC, Johnson DH, Holt JT. Tait DL, et al. Among authors: holt jt. Clin Cancer Res. 1997 Nov;3(11):1959-68. Clin Cancer Res. 1997. PMID: 9815585 Clinical Trial.

5

Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability.

Tait DL, Obermiller PS, Hatmaker AR, Redlin-Frazier S, Holt JT. Tait DL, et al. Among authors: holt jt. Clin Cancer Res. 1999 Jul;5(7):1708-14. Clin Cancer Res. 1999. PMID: 10430073 Clinical Trial.

6

Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNA.

Holt JT, Arteaga CB, Robertson D, Moses HL. Holt JT, et al. Hum Gene Ther. 1996 Jul 10;7(11):1367-80. doi: 10.1089/hum.1996.7.11-1367. Hum Gene Ther. 1996. PMID: 8818724 No abstract available.

7

Antisense mapping of the c-fos promoter: role of the serum response element.

Robinson-Benion C, Kamata N, Holt JT. Robinson-Benion C, et al. Among authors: holt jt. Antisense Res Dev. 1991 Spring;1(1):21-33. doi: 10.1089/ard.1991.1.21. Antisense Res Dev. 1991. PMID: 1822246

8

Antisense rescue defines specialized and generalized functional domains for c-Fos protein.

Holt JT. Holt JT. Mol Cell Biol. 1993 Jun;13(6):3821-30. doi: 10.1128/mcb.13.6.3821-3830.1993. Mol Cell Biol. 1993. PMID: 8497282 Free PMC article.

9

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.

Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Thompson ME, et al. Among authors: holt jt. Nat Genet. 1995 Apr;9(4):444-50. doi: 10.1038/ng0495-444. Nat Genet. 1995. PMID: 7795653

10

Gene transplantation: combined antisense inhibition and gene replacement strategies.

Robinson-Benion C, Li YX, Holt JT. Robinson-Benion C, et al. Among authors: holt jt. Leukemia. 1994 Apr;8 Suppl 1:S152-5. Leukemia. 1994. PMID: 8152283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters